Qingjiang Chen

489 total citations
27 papers, 358 citations indexed

About

Qingjiang Chen is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Qingjiang Chen has authored 27 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 11 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Qingjiang Chen's work include Lymphoma Diagnosis and Treatment (10 papers), Immune Cell Function and Interaction (6 papers) and Viral-associated cancers and disorders (6 papers). Qingjiang Chen is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Immune Cell Function and Interaction (6 papers) and Viral-associated cancers and disorders (6 papers). Qingjiang Chen collaborates with scholars based in China, United States and Australia. Qingjiang Chen's co-authors include Mingzhi Zhang, Lexin Wang, Qingxia Fan, Xinguang Cao, Xiaobing Chen, Xiaorui Fu, Zhaoming Li, Xudong Zhang, Mingzhi Zhang and Ling Li and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Qingjiang Chen

24 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingjiang Chen China 9 236 161 86 72 33 27 358
Feifei Chen China 11 302 1.3× 186 1.2× 67 0.8× 57 0.8× 20 0.6× 19 425
Da‐Lei Zhou China 11 153 0.6× 89 0.6× 122 1.4× 48 0.7× 31 0.9× 24 352
Ting‐Yan Shi China 7 270 1.1× 132 0.8× 80 0.9× 60 0.8× 33 1.0× 10 371
Hirotaka Shimaoka Japan 8 212 0.9× 99 0.6× 183 2.1× 30 0.4× 18 0.5× 8 347
Mary‐Kate Malecek United States 5 203 0.9× 100 0.6× 112 1.3× 26 0.4× 58 1.8× 5 300
Youdong Lin China 9 241 1.0× 190 1.2× 73 0.8× 26 0.4× 43 1.3× 13 347
Zhigang Cao China 11 229 1.0× 151 0.9× 70 0.8× 27 0.4× 15 0.5× 35 331
Joana Assis Portugal 14 195 0.8× 122 0.8× 100 1.2× 16 0.2× 21 0.6× 30 392
Marzia Leotta Italy 8 337 1.4× 252 1.6× 80 0.9× 77 1.1× 9 0.3× 15 481
Yoshihito Utada Japan 10 133 0.6× 112 0.7× 106 1.2× 77 1.1× 35 1.1× 21 294

Countries citing papers authored by Qingjiang Chen

Since Specialization
Citations

This map shows the geographic impact of Qingjiang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingjiang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingjiang Chen more than expected).

Fields of papers citing papers by Qingjiang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingjiang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingjiang Chen. The network helps show where Qingjiang Chen may publish in the future.

Co-authorship network of co-authors of Qingjiang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Qingjiang Chen. A scholar is included among the top collaborators of Qingjiang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingjiang Chen. Qingjiang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Meng‐Qiu, et al.. (2025). YTHDF2 regulates the adriamycin (ADM) resistance in NKTCL by modulating the m6A modification of SLC16A9. Translational Oncology. 59. 102448–102448.
2.
Feng, Xiaoyan, Mengke Fan, Qingjiang Chen, et al.. (2024). Real-world study and prognostic analysis of angioimmunoblastic T-cell lymphoma. Frontiers in Immunology. 15. 1481301–1481301.
3.
Song, Yun, Chao Wang, Yifan Yang, et al.. (2024). Mild Therapeutic Hypothermia Alleviated Myocardial Ischemia/Reperfusion Injury via Targeting SLC25A10 to Suppress Mitochondrial Apoptosis. Journal of Cardiovascular Translational Research. 17(4). 946–958. 4 indexed citations
4.
Zhang, Xudong, Xiaoyan Feng, Meng Dong, et al.. (2023). Decitabine combined with RDHAP regimen in relapsed/refractory diffuse large B cell lymphoma. Cancer Medicine. 12(7). 8134–8143. 7 indexed citations
5.
Chen, Qingjiang, et al.. (2023). Univariable and multivariable mendelian randomization study revealed the modifiable risk factors of urolithiasis. PLoS ONE. 18(8). e0290389–e0290389. 4 indexed citations
6.
Zhao, Lu, et al.. (2023). Clinical and imaging features of lymphomatosis cerebri: analysis of 8 cases and systematic review of the literature. Clinical and Experimental Medicine. 23(8). 4673–4680. 2 indexed citations
7.
Zhang, Yue, Wenhua Wang, Zeyuan Wang, et al.. (2022). Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China. Journal of Cancer Research and Clinical Oncology. 149(7). 3989–4003. 6 indexed citations
8.
Dong, Meng, et al.. (2021). GPNMB promotes the progression of diffuse large B cell lymphoma via YAP1-mediated activation of the Wnt/β-catenin signaling pathway. Archives of Biochemistry and Biophysics. 710. 108998–108998. 8 indexed citations
9.
Wang, Xin, Meng Dong, Jingjing Wu, et al.. (2020). DDGP vs. SMILE in Relapsed/Refractory Extranodal Natural Killer/T‐cell Lymphoma, Nasal Type: A Retrospective Study of 54 Patients. Clinical and Translational Science. 14(1). 405–411. 6 indexed citations
10.
Zhang, Xudong, Xiaorui Fu, Meng Dong, et al.. (2018). Conserved cell populations in doxorubicin-resistant human nasal natural killer/T cell lymphoma cell line: super multidrug resistant cells?. Cancer Cell International. 18(1). 150–150. 5 indexed citations
11.
Dong, Meng, Xudong Zhang, Zhaoming Li, et al.. (2018). Patients over 40 years old with precursor T-cell lymphoblastic lymphoma have different prognostic factors comparing to the youngers. Scientific Reports. 8(1). 1088–1088. 8 indexed citations
12.
Zhang, Xudong, Meng Dong, Ling Li, et al.. (2017). Human immunodeficiency virus-negative plasmablastic lymphoma. Medicine. 96(7). e6171–e6171. 12 indexed citations
13.
Fu, Xiaorui, Xu Dong Zhang, Xin Li, et al.. (2017). Phosphatase and tensin homolog (PTEN) is down-regulated in human NK/T-cell lymphoma and corrects with clinical outcomes. Medicine. 96(29). e7111–e7111. 8 indexed citations
14.
Yang, Li, Xudong Zhang, Mingzhi Zhang, et al.. (2012). Increased Nanog Expression Promotes Tumor Development and Cisplatin Resistance in Human Esophageal Cancer Cells. Cellular Physiology and Biochemistry. 30(4). 943–952. 30 indexed citations
15.
Jia, Huimin, et al.. (2011). Wnt5a expression in the hindgut of fetal rats with chemically induced anorectal malformations—studies in the ETU rat model. International Journal of Colorectal Disease. 26(4). 493–499. 12 indexed citations
16.
Chen, Qingjiang, et al.. (2011). miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42. Digestive Diseases and Sciences. 56(7). 2009–2016. 116 indexed citations
17.
Chen, Qingjiang & Mingzhi Zhang. (2011). Significance of SOX2 mRNA and protein expression in esophageal squamous cell carcinoma. World Chinese Journal of Digestology. 19(16). 1698–1698. 1 indexed citations
18.
19.
Chen, Qingjiang, Mingzhi Zhang, & Lexin Wang. (2010). Gensenoside Rg3 Inhibits Hypoxia-induced VEGF Expression in Human Cancer Cells. Cellular Physiology and Biochemistry. 26(6). 849–858. 70 indexed citations
20.
Chen, Qingjiang. (2005). Effects of astragalus membranaous on proliferation and transforming growth factor-β1 scretion of human renal interstitial fibroblasts. Journal of Zhengzhou University. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feifei Chen Breakdown of academic impact, for papers by Da‐Lei Zhou Breakdown of academic impact, for papers by Ting‐Yan Shi Breakdown of academic impact, for papers by Hirotaka Shimaoka Breakdown of academic impact, for papers by Mary‐Kate Malecek Breakdown of academic impact, for papers by Youdong Lin Breakdown of academic impact, for papers by Zhigang Cao Breakdown of academic impact, for papers by Joana Assis Breakdown of academic impact, for papers by Marzia Leotta Breakdown of academic impact, for papers by Yoshihito Utada
Rankless by CCL
2026